Rare Casbane Diterpenoids from Sinularia depressa
Journal of Natural Products, 2010, Vol. 73, No. 2 137
an internal standard. NOESY spectra were obtained with different
mixing times (0.180, 0.250, and 0.400 s). EIMS and HREIMS data
were obtained on a Finnigan-MAT-95 mass spectrometer. ESIMS and
HRESIMS spectra were recorded on a Q-TOF Micro LC-MS-MS mass
spectrometer. Reversed-phase HPLC (Agilent 1100 series liquid
chromatography using a VWD G1314A detector at 210 nm and a
semipreparative ODS-HG-5 [5 µm, 10 mm (i.d.) × 25 cm] column
was also employed. Commercial Si gel (Qing Dao Hai Yang Chemical
Group Co., 200-300 and 400-600 mesh) was used for column
chromatography (CC), and precoated Si gel plates (Yan Tai Zi Fu
Chemical Group Co., G60 F-254) were used for analytical and
preparative TLC.
8,10-Dihydroxy-iso-depressin (13): colorless oil; [R]2D5 -39.0
(c 0.20, CHCl3); CD (c 1.42 × 10-3 M, n-hexane) λ (∆ε) 203 (0.06),
217 (0.8), 262 (-2.3); IR (KBr) νmax 1668 cm-1; 1H and 13C NMR in
Tables 1 and 2; HRESIMS m/z 341.2096 (calcd for C20H30O3Na,
341.2093).
Preparation of MTPA Esters. (R)- and (S)-MTPA-Cl (10 µL) and
a catalytic amount of DMAP were separately added to two different
aliquots of alcohol 7 (1.0 mg each) in dry CH2Cl2 (0.5 mL), and the
resulting mixtures were allowed to stand at room temperature for 12 h.
After the evaporation of the solvent, the mixtures were purified on
preparative TLC (SiO2, light petroleum ether/Et2O, 8:2), affording pure
(S)- and (R)-MTPA esters of 7, respectively. The MTPA esters of 8
were prepared following the same procedure.
Collection and Extraction of the Animal Material. Specimens of
Sinularia depressa were collected at Lingshui Bay, Hainan Province,
China, in July 2004, at a depth of 20 m and were frozen immediately
after collection. A voucher specimen of S. depressa (LS-338) is
available for inspection at the Shanghai Institute of Materia Medica,
CAS. The frozen material (510 g dry weight) was cut into small pieces
and extracted exhaustively with acetone at room temperature (3 × 1.5
L). The organic extract was evaporated to give a residue, which was
partitioned between Et2O and H2O. The Et2O solution was concentrated
under reduced pressure to give a dark brown residue (9.6 g).
Purification of Compounds 5-13. The Et2O extract was fraction-
ated by gradient Si gel column chromatography eluting with a step
gradient (0-100% acetone in light petroleum ether) to yield three
casbane-containing fractions [A (900 mg), B (1.2 g), C (500 mg)]. An
aliquot of fraction A (50.0 mg) was further purified by Si gel CC (light
petroleum ether/Et2O, 95:5) to yield 5 (5.6 mg) and 6 (6.2 mg). An
aliquot of fraction B (61.0 mg) was subjected to a RP-HPLC purification
[semipreparative ODS-HG-5 (5 µm, 250 × 10 mm), MeCN/H2O, 70:
30, 2.0 mL/min], obtaining 9 (4.7 mg; tR 16.7 min), 11 (5.5 mg; tR
19.2 min), 12 (4.3 mg; tR 22.3 min), and 10 (5.0 mg; tR 25.5 min).
Fraction C was fractionated by Si gel CC (light petroleum ether/Et2O,
6:4 and 5:5) to give a mixture, which was further purified on a Sephadex
LH20 column (light petroleum ether, CHCl3, CH3OH, 2:1:1), yielding
the main component, 7 (134.5 mg), along with 8 (1.6 mg) and 13 (1.1
mg).
(S)-MTPA ester of 7: selected 1H NMR values (CDCl3, 400 MHz)
δ 6.27 (1Η, d, J ) 10.5 Hz, H-3), 5.65 (1H, ddd, J ) 14.0, 10.0, 4.0
Hz, H-10), 5.17 (1H, t, J ) 6.6 Hz, H-7), 5.06 (1H, d, J ) 9.3 Hz,
H-11), 3.53 (3H, s, OMe), 3.50 (1H, m, H-6a), 3.02 (1H, dd, J ) 13.8,
5.7, H-6b), 2.41 (1H, m, H-13a), 2.35 (1H, m, H-9a), 2.18 (1H, m,
H-9b), 1.85 (1H, m, H-13b), 1.85 (3H, s, H3-18), 1.72 (3H, s, H3-20),
1.64 (3H, s, H3-19), 1.18 (3H, s, H3-16), 1.05 (3H, s, H3-17).
(R)-MTPA ester of 7: selected 1H NMR values (CDCl3, 400 MHz)
δ 6.26 (1Η, d, J ) 10.5 Hz, H-3), 5.62 (1H, ddd, J ) 14.0, 10.0, 4.0
Hz, H-10), 5.19 (1H, t, J ) 6.6 Hz, H-7), 4.94 (1H, d, J ) 9.3 Hz,
H-11), 3.54 (3H, s, OMe), 3.52 (1H, m, H-6a), 3.03 (1H, dd, J ) 13.8,
5.7 Hz, H-6b), 2.45 (1H, m, H-9a), 2.35 (1H, m H-13a,), 2.28 (1H, m,
H-9b), 1.85 (1H, m, H-13b), 1.85 (3H, s, H3-18), 1.71 (3H, s, H3-20),
1.66 (3H, s, H3-19), 1.18 (3H, s, H3-16), 1.05 (3H, s, H3-17).
(S)-MTPA ester of 8: selected 1H NMR values (CDCl3, 400 MHz)
δ 6.02 (1Η, d, J ) 10.2 Hz, H-3), 5.66 (1H, ddd, J ) 13.4, 9.8, 3.8
Hz, H-10), 5.35 (1H, br d, J ) 8.3 Hz, H-7), 5.28 (1H, d, J ) 9.3 Hz,
H-11), 3.61 (1H, dd, J ) 14.3, 10.9 Hz, H-6a), 3.53 (3H, s, OMe),
2.92 (1H, br d, J ) 14.3 Hz, H-6b), 2.44 (1H, br d, J ) 11.4 Hz,
H-9a), 2.20 (1H, dd, J ) 11.4, 10.5 Hz, H-9b,), 2.32 (1H, m, H-13a),
2.16 (1H, m, H-13b), 1.99 (1H, m, H-14b), 1.26 (1H, m, H-14a), 1.78
(3H, s, H3-18), 1.66 (3H, s, H3-19), 1.62 (3H, s, H3-20), 1.17 (3H, s,
H3-16), 1.10 (3H, s, H3-17), 1.04 (1H, m, H-2), 0.56 (1H, m, H-1).
(R)-MTPA ester of 8: selected 1H NMR values (CDCl3, 400 MHz)
δ 6.01 (1Η, d, J ) 10.2 Hz, H-3), 5.65 (1H, ddd, J ) 13.2, 9.7, 3.7
Hz, H-10), 5.36 (1H, br d, J ) 8.3 Hz, H-7), 5.17 (1H, d, J ) 9.3 Hz,
H-11), 3.60 (1H, dd, J ) 14.3, 11.0 Hz, H-6a), 3.53 (3H, s, OMe),
2.93 (1H, br d, J ) 14.3 Hz, H-6b), 2.52 (1H, br d, J ) 11.4 Hz,
H-9a), 2.35 (1H, dd, J ) 11.4, 10.4 Hz, H-9b,), 2.24 (1H, m, H-13a),
2.13 (1H, m, H-13b), 2.01 (1H, m, H-14a), 1.25 (1H, m, H-14b), 1.78
(3H, s, H3-18), 1.68 (3H, s, H3-19), 1.58 (3H, s, H3-20), 1.15 (3H, s,
H3-16), 1.09 (3H, s, H3-17), 1.04 (1H, m, H-2), 0.55 (1H, m, H-1).
Oxidation of Compounds 7 and 8. Compounds 7 (6.0 mg) and 8
(1.1 mg) were separately treated with Dess-Martin reagent in CH2Cl2
(1 mL). The reaction mixtures were stirred at room temperature for
18 h. The excess Dess-Martin reagent was destroyed by adding
isopropyl alcohol, and the mixtures were washed with NaHCO3 solution.
The organic phases were separated and concentrated under vacuum,
and the residues were purified by TLC chromatography on Si gel CC
(light petroleum ether/diethyl ether, 7:3) to give 14 (4.6 mg, from 7)
and a compound with spectroscopic data identical with those of natural
9 (0.4 mg, from 8).
Depressin (5): colorless oil; [R]2D5 -80.0 (c 0.26, CHCl3); CD
(c 2.10 × 10-3 M, n-hexane) λ (∆ε) 204 (7.4), 249 (-2.1); UV (EtOH)
λ
max (log ε) 271 (3.56); IR (KBr) νmax 1655 cm-1; 1H and 13C NMR in
Tables 1 and 2; HREIMS m/z 286.2291 (calcd for C20H30O, 286.2297).
1-epi-Depressin (6): colorless oil; [R]2D5 +34.0 (c 0.25, CHCl3); CD
(c 1.05 × 10-3 M, n-hexane) λ (∆ε) 205 (5.1), 236 (0.2); UV (MeOH)
λ
max (log ε) 274 (5.0) nm; IR (KBr) νmax 1653 cm-1; 1H and 13C NMR
in Tables 1 and 2; HREIMS m/z 286.2306 (calcd for C20H30O,
286.2297).
10-Hydroxydepressin (7): colorless oil; [R]2D5 -218 (c 0.55, CHCl3);
CD (c 9.93 × 10-4 M, n-hexane) λ (∆ε) 202 (27.6), 252 (-17.7); UV
(EtOH) λmax (log ε) 270 (4.76); IR (KBr) νmax 3388, 1650 cm-1; H
1
and 13C NMR in Tables 1 and 2; HREIMS m/z 302.2240 (calcd for
C20H30O2, 302.2246).
1-epi-10-Hydroxydepressin (8): colorless oil; [R]2D5 +4.5 (c 0.54,
CHCl3); CD (c 9.93 × 10-4 M, n-hexane) λ (∆ε) 206 (31.9), 232
(-10.5); UV (EtOH) λmax (log ε) 270 (4.82); IR (KBr) νmax 3399, 1651
cm-1; H and 13C NMR in Tables 1 and 2; HRESIMS m/z 325.2140
1
1
(calcd for C20H30O2Na, 325.2144).
10-Oxodepressin (14): colorless oil; [R]2D5 -76 (c 0.4, CHCl3); H
1-epi-10-Oxodepressin (9): colorless oil; [R]2D5 +11.0 (c 0.27,
CHCl3);15 CD (c 1.00 × 10-3 M, n-hexane) λ (∆ε) 201 (2.1), 241 (2.1),
and 13C NMR in Tables 1 and 2; ESIMS [M + Na]+ m/z 323.
Synthetic 1-epi-10-oxodepressin: colorless oil; [R]2D5 +210 (c 0.02,
CHCl3);15 1H and 13C NMR identical to those of 9 in Tables 1 and 2;
ESIMS [M + Na]+ m/z 323.
1
265 (-1.1); IR (KBr) νmax 1668 cm-1; H and 13C NMR in Tables 1
and 2; HREIMS m/z 300.2089 (calcd for C20H28O2, 300.2089).
10-Oxo-11,12-dihydrodepressin (10): colorless oil; [R]2D5 +155
(c 0.13, CHCl3); CD (c 8.28 × 10-4 M, n-hexane) λ (∆ε) 202 (43.0),
Conformational Analysis. Structures were obtained by unrestrained
SA/EM.16 Calculations were performed with Sander module of
AMBER10,17 using AMBER GAFF parametrization18 and RESP
charges,19 fitted from ab initio 6-31G* calculations performed with
GAMESS.20 Starting structures for all molecules were built with
Ghemical 2.95.21 Conformational sampling was obtained by unre-
strained simulated annealing. The starting structure of each molecule
underwent 200 SA cycles of 100 000 MD steps, where system
temperature was linearly raised from 10 to 1200 K (steps 1 to 5000),
then kept constant at 1200 K (steps 5001 to 50 000), and finally, linearly
decreased down to 10 K (steps 50 001 to 100 000). A time step of 1
fs, with no constraints or restraints on bond lengths, a nonbonded cutoff
of 16 Å, and a 0.05 fs time constant for heat bath coupling were used,
with all other parameters set at their default values. trans-Alkene bonds
were forced into a trans orientation (ω ) 180°) by torsional constraints
1
234 (-26.6); 268 (9.9); IR (KBr) νmax 1709, 1647 cm-1; H and 13C
NMR in Tables 1 and 2; HREIMS m/z 302.2247 (calcd for C20H30O2,
302.2246).
1-epi-10-Oxo-11,12-dihydrodepressin (11): colorless oil; [R]D25
-74.0 (c 0.24, CHCl3); CD (c 1.32 × 10-3 M, n-hexane) λ (∆ε) 204
1
(7.1), 232 (-0.7), 268 (3.4); IR (KBr) νmax 1709, 1653 cm-1; H and
13C NMR in Tables 1 and 2; HREIMS m/z 302.2250 (calcd for
C20H30O2, 302.2246).
2-epi-10-Oxo-11,12-dihydrodepressin (12): colorless oil; [R]D25
+133 (c 0.28, CHCl3); CD (c 1.16 × 10-3 M, n-hexane) λ (∆ε) 204
(-7.6), 235 (2.6), 267 (-1.7); IR (KBr) νmax 1709, 1655 cm-1; 1H and
13C NMR in Tables 1 and 2; HREIMS m/z 302.2257 (calcd for
C20H30O2, 302.2246).